| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | p53 binding | 4.39e-05 | 77 | 3 | 2 | GO:0002039 | |
| GeneOntologyBiologicalProcess | regulation of signal transduction by p53 class mediator | 9.86e-05 | 119 | 3 | 2 | GO:1901796 | |
| GeneOntologyBiologicalProcess | signal transduction by p53 class mediator | 2.54e-04 | 191 | 3 | 2 | GO:0072331 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 9.11e-04 | 362 | 3 | 2 | GO:0034504 | |
| GeneOntologyCellularComponent | sarcomere | 4.21e-04 | 249 | 3 | 2 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 5.05e-04 | 273 | 3 | 2 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 5.70e-04 | 290 | 3 | 2 | GO:0043292 | |
| GeneOntologyCellularComponent | supramolecular fiber | 9.18e-03 | 1179 | 3 | 2 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 9.30e-03 | 1187 | 3 | 2 | GO:0099081 | |
| MousePheno | abnormal artery development | 2.68e-04 | 133 | 3 | 2 | MP:0003410 | |
| MousePheno | abnormal angiogenesis | 2.08e-03 | 372 | 3 | 2 | MP:0000260 | |
| MousePheno | abnormal artery morphology | 2.90e-03 | 440 | 3 | 2 | MP:0002191 | |
| MousePheno | abnormal vascular development | 4.39e-03 | 542 | 3 | 2 | MP:0000259 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.23e-04 | 157 | 2 | 2 | MM15226 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.28e-04 | 160 | 2 | 2 | M27498 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 4.64e-04 | 304 | 2 | 2 | MM14960 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 6.50e-04 | 360 | 2 | 2 | M27267 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 2.96e-03 | 768 | 2 | 2 | MM14851 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 5.25e-03 | 1022 | 2 | 2 | MM15436 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 9.67e-03 | 1387 | 2 | 2 | M734 | |
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 3.59e-05 | 121 | 3 | 2 | 31900314 | |
| Interaction | PRKAG1 interactions | 1.58e-04 | 147 | 3 | 2 | int:PRKAG1 | |
| Interaction | PRKAA2 interactions | 4.27e-04 | 242 | 3 | 2 | int:PRKAA2 | |
| Interaction | FBXW11 interactions | 1.62e-03 | 473 | 3 | 2 | int:FBXW11 | |
| Interaction | CDC37 interactions | 3.00e-03 | 645 | 3 | 2 | int:CDC37 | |
| Interaction | CUL4B interactions | 3.82e-03 | 728 | 3 | 2 | int:CUL4B | |
| Interaction | GSK3B interactions | 5.40e-03 | 868 | 3 | 2 | int:GSK3B | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN | 3.84e-03 | 950 | 3 | 2 | M19907 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.25e-05 | 170 | 3 | 2 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.82e-05 | 181 | 3 | 2 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.87e-05 | 182 | 3 | 2 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.25e-05 | 189 | 3 | 2 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| Drug | Deoxyglucose | 3.12e-05 | 74 | 3 | 2 | ctd:D003847 | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; HL60; HG-U133A | 2.24e-04 | 198 | 3 | 2 | 1625_DN | |
| Drug | 5-methylcytosine | 3.11e-04 | 233 | 3 | 2 | CID000065040 | |
| Disease | lymphocyte count | 7.14e-03 | 1464 | 3 | 2 | EFO_0004587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YMVMEYCVCGMQEML | 126 | Q15831 | |
| IYREMMDMCFIICTM | 306 | Q8N0Z2 | |
| NVYMLHMMYQAMGVC | 336 | Q9NRG4 | |
| HMMYQAMGVCLYMQD | 341 | Q9NRG4 |